Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21,943 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systemic administration of clinical-grade multilineage-differentiating stress-enduring cells ameliorates hypoxic-ischemic brain injury in neonatal rats.
Ueda K, Sato Y, Shimizu S, Suzuki T, Onoda A, Miura R, Go S, Mimatsu H, Kitase Y, Yamashita Y, Irie K, Tsuji M, Mishima K, Mizuno M, Takahashi Y, Dezawa M, Hayakawa M. Ueda K, et al. Among authors: suzuki t. Sci Rep. 2023 Sep 11;13(1):14958. doi: 10.1038/s41598-023-41026-3. Sci Rep. 2023. PMID: 37696826 Free PMC article.
Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in Rat.
Sugiyama Y, Sato Y, Kitase Y, Suzuki T, Kondo T, Mikrogeorgiou A, Horinouchi A, Maruyama S, Shimoyama Y, Tsuji M, Suzuki S, Yamamoto T, Hayakawa M. Sugiyama Y, et al. Among authors: suzuki s, suzuki t. Front Neurol. 2018 Sep 11;9:757. doi: 10.3389/fneur.2018.00757. eCollection 2018. Front Neurol. 2018. PMID: 30254603 Free PMC article.
Establishment of a Novel Fetal Growth Restriction Model and Development of a Stem-Cell Therapy Using Umbilical Cord-Derived Mesenchymal Stromal Cells.
Kitase Y, Sato Y, Arai S, Onoda A, Ueda K, Go S, Mimatsu H, Jabary M, Suzuki T, Ito M, Saito A, Hirakawa A, Mukai T, Nagamura-Inoue T, Takahashi Y, Tsuji M, Hayakawa M. Kitase Y, et al. Among authors: suzuki t. Front Cell Neurosci. 2020 Jul 28;14:212. doi: 10.3389/fncel.2020.00212. eCollection 2020. Front Cell Neurosci. 2020. PMID: 32848614 Free PMC article.
Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy.
Suzuki T, Sato Y, Kushida Y, Tsuji M, Wakao S, Ueda K, Imai K, Iitani Y, Shimizu S, Hida H, Temma T, Saito S, Iida H, Mizuno M, Takahashi Y, Dezawa M, Borlongan CV, Hayakawa M. Suzuki T, et al. J Cereb Blood Flow Metab. 2021 Jul;41(7):1707-1720. doi: 10.1177/0271678X20972656. Epub 2020 Nov 22. J Cereb Blood Flow Metab. 2021. PMID: 33222596 Free PMC article.
Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial.
Matsuyama N, Shimizu S, Ueda K, Suzuki T, Suzuki S, Miura R, Katayama A, Ando M, Mizuno M, Hirakawa A, Hayakawa M, Sato Y. Matsuyama N, et al. Among authors: suzuki s, suzuki t. BMJ Open. 2022 Apr 26;12(4):e057073. doi: 10.1136/bmjopen-2021-057073. BMJ Open. 2022. PMID: 35473726 Free PMC article. Clinical Trial.
Altered offspring neurodevelopment in an L-NAME-induced preeclampsia rat model.
Nakamura N, Ushida T, Onoda A, Ueda K, Miura R, Suzuki T, Katsuki S, Mizutani H, Yoshida K, Tano S, Iitani Y, Imai K, Hayakawa M, Kajiyama H, Sato Y, Kotani T. Nakamura N, et al. Among authors: suzuki t. Front Pediatr. 2023 Jul 13;11:1168173. doi: 10.3389/fped.2023.1168173. eCollection 2023. Front Pediatr. 2023. PMID: 37520045 Free PMC article.
21,943 results
You have reached the last available page of results. Please see the User Guide for more information.